Studying ASSIP, a Short-Term Program to Prevent Future Suicide Attempts in Adults Receiving Psychiatric Care in Sweden

What this Trial Is About

Researchers are evaluating the Attempted Suicide Short Intervention Program ASSIP to prevent future suicidal behavior in people who have recently attempted suicide. This multicenter, randomized controlled trial in Sweden aims to compare ASSIP as a supplement to usual psychiatric care versus usual care alone. The study also explores factors that may influence ASSIPs effectiveness and assesses its cost-effectiveness. Participants receive either ASSIP plus standard treatment or standard treatment alone. ASSIP involves up to four therapy sessions, including a videotaped narrative interview, video playback with discussion, development of a personalized prevention plan, and an optional mini-exposure session. Therapists also send standardized letters to participants over two years to maintain contact. Standard treatment includes multidisciplinary care such as psychotherapy, medication, and referrals to specialist or primary care as needed. Participants undergo baseline interviews and self-assessments, followed by telephone interviews and self-assessment scales at 3, 12, and 24 months. Researchers collect data from medical records, national health and social insurance registers, and track suicide attempts and health outcomes over two years. The primary outcomes include the number of suicide attempts and cost-effectiveness over this period, with secondary measures covering suicidal thoughts, quality of life, healthcare use, and employment status.

A Randomized Clinical Study of "Attempted Suicide Short Intervention Program" in Swedish Healthcare - ASSIP